LOG IN
SIGN UP
MARKET
IQV
IQV
Iqvia Hldgs Inc
NYSE
Real-time Quotes | Nasdaq Last Sale
217.50
+1.50
+0.69%
Opening 13:21 07/07 EDT
OPEN
214.95
PREV CLOSE
216.00
HIGH
217.78
LOW
214.95
VOLUME
312.26K
TURNOVER
40.04M
52 WEEK HIGH
285.61
52 WEEK LOW
194.67
MARKET CAP
41.17B
P/E (TTM)
39.22
1D
5D
1M
3M
1Y
5Y
Accolade (ACCD) Reports Q1 Loss, Tops Revenue Estimates
Accolade (ACCD) delivered earnings and revenue surprises of 45.21% and 3.80%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 6d ago
IQV vs. APP: Which Stock Should Value Investors Buy Now?
IQV vs. APP: Which Stock Is the Better Value Option?
Zacks · 06/28 15:40
Why a Hold Strategy is Apt for IQVIA Holdings (IQV) Stock Now
IQVIA's (IQV) enormous treasure trove of information is a distinguishing asset.
Zacks · 06/24 16:50
How Is The Market Feeling About IQVIA Hldgs?
IQVIA Hldgs's (NYSE:IQV) short percent of float has fallen 5.88% since its last report. The company recently reported that it has 2.10 million shares sold short, which is 1.12% of all regular shares that are available for trading.
Benzinga · 06/16 15:06
North Carolina should lead in development of artificial intelligence
If North Carolina wants to continue its rate of economic expansion, higher education, business and government should work together to further promote the development of artificial intelligence.
American City Business Journals · 06/15 11:57
Global Oncology R&D Surges While Cancer Care Disruptions Ease, Says IQVIA Institute for Human Data Science
RESEARCH TRIANGLE PARK, N.C., June 01, 2022--Global research and development in oncology continues to surge with historically high levels of trial starts in 2021, up 56% from 2016. Also, a record 30 novel active substances launched globally last year, acco...
Business Wire · 06/01 12:00
Here's Why You Should Retain IQVIA Holdings (IQV) Stock Now
IQVIA (IQV) rides on a solid healthcare-specific global IT infrastructure and analytics-driven clinical development skills. However, a weak balance sheet is worrisome.
Zacks · 05/31 18:28
Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks · 05/30 13:40
No Data
Learn about the latest financial forecast of IQV. Analyze the recent business situations of Iqvia Hldgs Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating
Based on 21 analysts
Buy
Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
38.10%Strong Buy
57.14%Buy
4.76%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average IQV stock price target is 262.00 with a high estimate of 290.00 and a low estimate of 235.00.
Current 217.50
EPS
Actual
Estimate
0.641.281.912.55
Institutional Holdings
Institutions: 1.02K
Institutional Holdings: 171.79M
% Owned: 90.76%
Shares Outstanding: 189.28M
TypeInstitutionsShares
Increased
332
7.35M
New
81
2.37M
Decreased
320
9.35M
Sold Out
108
1.21M
- Performance
- Asset Allocation
- Dividend History
No Data
Industry
Biotechnology & Medical Research
+2.81%
Pharmaceuticals & Medical Research
+0.66%
Key Executives
Chairman/President/Chief Executive Officer/Director
Ari Bousbib
Chief Financial Officer/Executive Vice President
Ronald Bruehlman
Corporate Executive
Kevin Knightly
Corporate Executive
Costa Panagos
Executive Vice President/General Counsel/Secretary
Eric Sherbet
Lead Director/Independent Director
John Leonard
Independent Director
Carol Burt
Independent Director
John Connaughton
Independent Director
John Danhakl
Independent Director
James Fasano
Independent Director
Colleen Goggins
Independent Director
Leslie Morris
Independent Director
Ronald Rittenmeyer
Independent Director
Todd Sisitsky
Independent Director
Sheila Stamps
No Data
No Data
About IQV
IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. The Company’s segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions, which primarily serves biopharmaceutical clients, is engaged in research and development and provides clinical research and clinical trial services. Contract Sales & Medical Solutions provides contract sales to both biopharmaceutical clients and the broader healthcare market.
Webull offers kinds of Iqvia Holdings Inc stock information, including NYSE:IQV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IQV stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading IQV stock methods without spending real money on the virtual paper trading platform.